Search Results - "Yahagi, Yuichi"

Combination of clofarabine, etoposide, and cyclophosphamide in adult relapsed/refractory acute lymphoblastic leukemia: a phase 1/2 dose-escalation study by the Japan Adult Leukemia Study Group by Saito, Takeshi, Hatta, Yoshihiro, Hayakawa, Fumihiko, Takahashi, Tsutomu, Hagihara, Maki, Iida, Hiroatsu, Minauchi, Koichiro, Yamazaki, Etsuko, Sugiura, Isamu, Murayama, Tohru, Sakura, Toru, Mori, Naoki, Imai, Kiyotoshi, Yahagi, Yuichi, Atsuta, Yoshiko, Saito, Akiko Moriya, Hirakawa, Akihiro, Kiyoi, Hitoshi, Matsumura, Itaru, Miyazaki, Yasushi

“…This phase 1/2 study aimed to identify the maximum tolerated dose, the recommended phase 2 dose (RP2D), and efficacy of the clofarabine, etoposide, and…”
Get full text

A Case of Primary Adrenal Insufficiency Triggered by Cytomegalovirus Infection after Obinutuzumab plus Bendamustine Therapy for Follicular Lymphoma by Nakamura, Takashi, Uryu, Hideki, Kawashima, Ryutaro, Ishiguro, Mizuki, Tanizawa, Mika, Kanazawa, Yasushi, Yamazaki, Hiroyuki, Yahagi, Yuichi

“…A 69-year-old man was diagnosed with follicular lymphoma (Grade 3A). Obinutuzumab combined with bendamustine (OB) therapy was initiated as salvage…”
Get full text

Miliary tuberculosis-associated hemophagocytic lymphohistiocytosis with a high level of soluble interleukin-2 receptor successfully treated with concomitant recombinant thrombomodulin: A case report by Uryu, Hideki, Nakamura, Takashi, Nakashima, Daisuke, Yamamoto, Kazuyoshi, Honda, Yu, Ishikawa, Masahiro, Tsujita, Tomohiro, Hata, Norihiko, Oinuma, Toshinori, Yamazaki, Hiroyuki, Yahagi, Yuichi

“…Hemophagocytic lymphohistiocytosis (HLH) is a fatal disease characterized by a highly inflammatory state due to the abnormal activation of T lymphocytes and…”
Get full text

Clinical significance of cancer-related fatigue in multiple myeloma patients by Suzuki, Kazuhito, Kobayashi, Nobuyuki, Ogasawara, Yoji, Shimada, Takaki, Yahagi, Yuichi, Sugiyama, Katsuki, Takahara, Shinobu, Saito, Takeshi, Minami, Jiro, Yokoyama, Hiroki, Kamiyama, Yutaro, Katsube, Atsushi, Kondo, Kazuhiro, Yanagisawa, Hiroyuki, Aiba, Keisuke, Yano, Shingo

“…Cancer-related fatigue (CRF) is one of the adverse events in multiple myeloma (MM) patients treated with cytotoxic agents, proteasome inhibitors (PIs), and…”
Get full text

Epstein-Barr Virus-associated Lymphoproliferative Disorder with Encephalitis Following Anti-thymocyte Globulin for Aplastic Anemia Resolved with Rituximab Therapy: A Case Report and Literature Review by Mashima, Kiyomi, Yano, Shingo, Yokoyama, Hiroki, Saito, Takeshi, Machishima, Tomohito, Shimada, Takaki, Yahagi, Yuichi, Takahara, Shinobu, Sugiyama, Katsuki, Ogasawara, Yoji, Minami, Jiro, Kamiyama, Yutaro, Katsube, Atsushi, Suzuki, Kazuhito, Ohshima, Sayaka, Yamada, Hisashi, Usui, Noriko, Aiba, Keisuke

“…Epstein-Barr virus (EBV)-associated lymphoproliferative disorders (LPDs) sometimes occur following Anti-thymocyte globulin (ATG) administration for allogenic…”
Get full text

Phase I trial of gemtuzumab ozogamicin in intensive combination chemotherapy for relapsed or refractory adult acute myeloid leukemia (AML): Japan Adult Leukemia Study Group (JALSG)‐AML206 study by Usui, Noriko, Takeshita, Akihiro, Nakaseko, Chiaki, Dobashi, Nobuaki, Fujita, Hiroyuki, Kiyoi, Hitoshi, Kobayashi, Yukio, Sakura, Toru, Yahagi, Yuichi, Shigeno, Kazuyuki, Ohwada, Chikako, Miyazaki, Yasushi, Ohtake, Shigeki, Miyawaki, Shuichi, Naoe, Tomoki, Ohnishi, Kazunori

“…In order to investigate better molecular‐target therapy for acute myeloid leukemia (AML), we conducted a phase I trial of a combination of gemtuzumab…”
Get full text

Pharmacokinetics for once-daily modified release formulation of tacrolimus hydrate in unrelated hematopoietic stem cell transplantation by Yano, Shingo, Mori, Shinichiro, Saito, Takeshi, Yokoyama, Hiroki, Machishima, Tomohito, Shimada, Takaki, Yahagi, Yuichi, Sugiyama, Katsuki, Ogasawara, Yoji, Takahara, Shinobu, Kasama, Kinuyo, Katsube, Atsushi, Kamiyama, Yutaro, Suzuki, Kazuhito, Inui, Yumiko, Usui, Noriko, Aiba, Keisuke, Yamashita, Takuya

“…A once-daily modified release formulation of oral tacrolimus (Tac QD) has been developed in response to the problem of nonadherence. However, there have been…”
Get full text

Salvage therapy for primary refractory and relapsed adult acute lymphoblastic leukemia by Yahagi, Yuichi, Usui, Noriko

Get more information

Usage of eltrombopag for chronic immune thrombocytopenia as a pretreatment for splenectomy by Uwagawa, Tadashi, Misawa, Takeyuki, Furukawa, Kenei, Ito, Ryusuke, Futagawa, Yasuro, Yahagi, Yuichi, Aiba, Kesuke, Yanaga, Katsuhiko

Get more information

Clinical significance of granule‐containing myeloma cells in patients with newly diagnosed multiple myeloma by Suzuki, Kazuhito, Yano, Shingo, Nishiwaki, Kaichi, Sano, Koji, Shimada, Takaki, Yahagi, Yuichi, Ogasawara, Yoji, Sugiyama, Katsuki, Takahara, Shinobu, Saito, Takeshi, Kasama, Kinuyo, Minami, Jiro, Yokoyama, Hiroki, Kamiyama, Yutaro, Katsube, Atsushi, Masuoka, Hidekazu, Katori, Mitsuji, Machishima, Tomohito, Ouchi, Aya, Dobashi, Nobuaki, Kaito, Ken, Usui, Noriko, Aiba, Keisuke

“…The clinical features and prognostic significance of myeloma cells containing granules remain unclear. The purpose of this retrospective study was to…”
Get full text

Rapid progression and unusual premortal diagnosis of mucormycosis in patients with hematologic malignancies: analysis of eight patients by Yano, Shingo, Minami, Jiro, Nishiwaki, Kaichi, Shimada, Takaki, Dobashi, Nobuaki, Yahagi, Yuichi, Takei, Yutaka, Takahara, Shinobu, Ogasawara, Yoji, Sugiyama, Katsuki, Yamaguchi, Yuko, Saito, Takeshi, Kasama, Kinuyo, Yokoyama, Hiroki, Machishima, Tomohito, Katsube, Atsushi, Usui, Noriko, Aiba, Keisuke

“…Mucormycosis is a rare but emerging group of life-threatening opportunistic mycoses. We described experience of eight patients who developed mucormycosis…”
Get full text

Inhibitors for Notch and gamma-secretase. Biology of T-cell leukemia by Yahagi, Yuichi, Usui, Noriko

Get more information

Two Cases of Mediastinal Gray Zone Lymphoma by Minami, Jiro, Dobashi, Nobuaki, Asai, Osamu, Yano, Shingo, Osawa, Hiroshi, Takei, Yutaka, Yahagi, Yuichi, Takahara, Shinobu, Ogasawara, Yoji, Yamaguchi, Yuko, Kobayashi, Tatsunosuke, Morikawa, Noriyuki, Nikaido, Takashi, Aiba, Keisuke, Usui, Noriko

“…Mediastinal gray zone lymphoma (MGZL) represents a range of tumors possessing characteristics of both nodular sclerosis classical Hodgkin lymphoma (NSHL) and…”
Get full text

Hematologists Should Order Endoscopic Examination to Specific Gastroenterologists Being Knowledgeable of Malignant Lymphoma in Case of Endoscopic Check-up of Gastrointestinal Malignant Lymphoma by Yamasaki, Takuji, Yahagi, Yuichi

“…(Background and aim) Malignant lymphoma (ML) of the stomach is a most popular lymphoma of the gastrointestinal tract. Especially we often see gastric MALT…”
Get full text

Administration schedule of daunorubicin for elderly patients with acute myelogenous leukemia: a single-institute experience by Dobashi, Nobuaki, Usui, Noriko, Yano, Shingo, Yahagi, Yuichi, Takei, Yutaka, Sugiyama, Katsuki, Takahara, Shinobu, Ogasawara, Yoji, Yamaguchi, Yuko, Saito, Takeshi, Yokoyama, Hiroki, Aiba, Keisuke

“…We evaluated the efficacy of daunorubicin  (40 mg/m(2)/day for 5 days, 200 mg/m(2)/cycle) combined with standard dose of cytarabine (100 mg/m(2)/day for 7…”
Get full text

Myelodysplastic syndrome with myelofibrosis in which azacitidine therapy was effective and cord blood transplantation was carried out by Ohba, Rie, Usui, Noriko, Ito, Yuta, Yamauchi, Hirofumi, Machishima, Tomohito, Ishii, Hiroto, Fukushima, Ryoko, Yokoyama, Hiroki, Shiota, Yuko, Yahagi, Yuichi, Yano, Shingo, Dobashi, Nobuaki, Aiba, Keisuke

“…Myelodysplastic syndrome with myelofibrosis (MDS-F) is a disease with a poor prognosis, and patients with this condition are at an increased risk of…”
Get more information

Intensifying daunorubicin in induction for patients with core binding factor leukemia by DOBASHI, Nobuaki, YAMAGUCHI, Yuko, ASAI, Osamu, YANO, Shingo, OSAWA, Hiroshi, YAHAGI, Yuichi, TAKEI, Yutaka, SUGIYAMA, Katsuki, SAITO, Takeshi, USUI, Noriko

Get full text

Chronic myeloid Leukemia - clinical practice according to the JSH guideline for hematological malignancies by Yahagi, Yuichi

Get more information

Gemtuzumab ozogamicin (GO) in relapsed/refractory patients with acute myeloid leukemia by Yamaguchi, Yuko, Usui, Noriko, Dobashi, Nobuaki, Yano, Shingo, Yahagi, Yuichi, Takei, Yutaka, Sugiyama, Katsunori, Ogasawara, Yoji, Saito, Takeshi, Minami, Jiro, Kobayashi, Tatsunosuke, Katsube, Atsushi, Kamiyama, Yutaro, Machishima, Tomohito, Morikawa, Noriyuki, Otsubo, Hiroko, Kaito, Ken, Asai, Osamu, Aiba, Keisuke

“…Gemtuzumab ozogamicin (GO) is a humanized anti-CD33 antibody, linked to calicheamicin, which has been approved in Japan recently. We conducted to evaluate the…”
Get more information

Intensified daunorubicin in induction therapy and autologous peripheral blood stem cell transplantation in postremission therapy (double-7 protocol) for adult acute myeloid leukemia by USUI, Noriko, DOBASHI, Nobuaki, TAKEI, Yutaka, SUGIYAMA, Katsuki, OGASAWARA, Yoji, OHTSUBO, Hiroko, KAITO, Ken, KOBAYASHI, Masayuki, ASAI, Osamu, YANO, Shingo, YAHAGI, Yuichi, SAITO, Takeshi, YAMAGUCHI, Yuko, KASAMA, Kinuyo, OKAWA, Yutaka, SEKIGUCHI, Naohiro

“…To investigate whether an intensified dose of daunorubicin (DNR) in induction therapy and autologous peripheral blood stem cell transplantation (PBSCT) in the…”
Get full text